tiprankstipranks
Trending News
More News >
Ascletis Pharma, Inc. (HK:1672)
:1672
Hong Kong Market

Ascletis Pharma, Inc. (1672) Financial Statements

Compare
8 Followers

Ascletis Pharma, Inc. Financial Overview

Ascletis Pharma, Inc.'s market cap is currently HK$12.49B. The company's EPS TTM is HK$-0.10177081187; its P/E ratio is -43.72; Ascletis Pharma, Inc. is scheduled to report earnings on August 15, 2025, and the estimated EPS forecast is HK$-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.28M¥ 56.60M¥ 54.09M¥ 76.88M¥ 35.00M
Gross Profit¥ 735.00K¥ 25.99M¥ -24.69M¥ 39.17M¥ -23.50M
Operating Income¥ -295.42M¥ -300.21M¥ -343.98M¥ -224.97M¥ -217.11M
EBITDA¥ -390.45M¥ -126.09M¥ -284.50M¥ -169.35M¥ -181.94M
Net Income¥ -300.94M¥ -144.72M¥ -314.84M¥ -199.02M¥ -209.24M
Balance Sheet
Cash & Short-Term Investments¥ 1.95B¥ 2.30B¥ 2.48B¥ 2.50B¥ 2.71B
Total Assets¥ 2.12B¥ 2.49B¥ 2.66B¥ 2.83B¥ 3.07B
Total Debt¥ 7.63M¥ 8.42M¥ 4.24M¥ 2.75M¥ 1.59M
Net Debt¥ -858.10M¥ -321.70M¥ -2.47B¥ -2.49B¥ -2.71B
Total Liabilities¥ 158.41M¥ 148.94M¥ 117.16M¥ 100.89M¥ 85.42M
Stockholders' Equity¥ 1.97B¥ 2.34B¥ 2.54B¥ 2.73B¥ 2.98B
Cash Flow
Free Cash Flow¥ -343.73M¥ -163.32M¥ -156.85M¥ -154.13M¥ -123.87M
Operating Cash Flow¥ -341.58M¥ -144.16M¥ -142.45M¥ -146.93M¥ -84.91M
Investing Cash Flow¥ 978.91M¥ 149.84M¥ -1.30B¥ -274.49M¥ 132.30M
Financing Cash Flow¥ -103.51M¥ -81.50M¥ -1.42M¥ -31.10M¥ -21.67M
Currency in CNY

Ascletis Pharma, Inc. Earnings and Revenue History

Ascletis Pharma, Inc. Debt to Assets

Ascletis Pharma, Inc. Cash Flow

Ascletis Pharma, Inc. Forecast EPS vs Actual EPS